The results of the application of the pre-formed physical factors and neuroprotective therapy for the rehabilitative treatment of the patients with diabetic retinopathy

Nazarova G.A.; Konchugova T.V.; Iurova O.V.; Turova E.A.; Rassulova M.A.; Sichinava N.V.; Morozova N.E.

doi:https://doi.org/

Nazarova G.A.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr meditsinskoĭ reabilitatsii i kurortologii" Minzdrava RF, Moskva

Konchugova T.V.

FGBU Rossiĭskiĭ nauchnyĭ tsentr kurortologii Minzdrava Rossii, Moskva

Iurova O.V.

GBUZ "MNPTs meditsinskoĭ reabilitatsii, vosstanovitel'noĭ i sportivnoĭ meditsiny" Departamenta zdravookhraneniia Moskvy

Turova E.A.

Siberian Regional Hospital №1, Yekaterinburg, Russia

Rassulova M.A.

GBUZ "MNPTs meditsinskoĭ reabilitatsii, vosstanovitel'noĭ i sportivnoĭ meditsiny" Departamenta zdravookhraneniia Moskvy

Sichinava N.V.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr meditsinskoĭ reabilitatsii i kurortologii" Minzdravsotsrazvitiia Rossii, Moskva

Morozova N.E.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr meditsinskoĭ reabilitatsii i kurortologii" Minzdrava Rossii

The results of the application of the pre-formed physical factors and neuroprotective therapy for the rehabilitative treatment of the patients with diabetic retinopathy

Authors:

Nazarova G.A., Konchugova T.V., Iurova O.V., Turova E.A., Rassulova M.A., Sichinava N.V., Morozova N.E.

More about the authors

Journal: Problems of Balneology, Physiotherapy and Exercise Therapy. 2013;90(5): 29‑32

Read: 832 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Nazarova GA, Konchugova TV, Iurova OV, Turova EA, Rassulova MA, Sichinava NV, Morozova NE. The results of the application of the pre-formed physical factors and neuroprotective therapy for the rehabilitative treatment of the patients with diabetic retinopathy. Problems of Balneology, Physiotherapy and Exercise Therapy. 2013;90(5):29‑32. (In Russ.)

Подписка 2026 Вопросы курортологии, физиотерапии и лечебной физической культуры (Problems of Balneology, Physiotherapy and Exercise Therapy)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Study of the levocarnitine efficacy for the treatment of moderate cognitive impairment in patients with hypertension. Russian Journal of Preventive Medicine. 2025;(4):45-50

Abstract:

To evaluate the effectiveness of the neuroprotective agent used to treat the patients presenting with non-proliferative diabetic retinopathy. The study included 114 patients (228 eyes) at the age varying from 42 to 70 who presented with diabetes mellitus and non-proliferative diabetic retinopathy. Three groups were formed depending on the mode of treatment. The patients in main group underwent endonasal electrophoresis of 0.1% semax preparation . Patients of the comparison group were treated with intranasal instillations of semax and those of the control group received only standard hypoglycemic therapy and treatment with Doxy-Hem. The patients of the first two groups showed positive dynamics of the studied functional characteristics (visual, perimetric, and electrophysiological ones). The most pronounced and long-standing (up to 12 months) positive effect on the visual function was documented in the main group. The results of the present study give reason to recommend the inclusion of endonasal electrophoresis of 0.1% semax in the combined rehabilitation treatment of the patients presenting with diabetes mellitus and non-proliferative diabetic retinopathy.

Keywords:

non-proliferative diabetic retinopathy

neuroprotective agents

endonasal electrophoresis

Authors:

Nazarova G.A.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr meditsinskoĭ reabilitatsii i kurortologii" Minzdrava RF, Moskva

Konchugova T.V.

FGBU Rossiĭskiĭ nauchnyĭ tsentr kurortologii Minzdrava Rossii, Moskva

Iurova O.V.

GBUZ "MNPTs meditsinskoĭ reabilitatsii, vosstanovitel'noĭ i sportivnoĭ meditsiny" Departamenta zdravookhraneniia Moskvy

Turova E.A.

Siberian Regional Hospital №1, Yekaterinburg, Russia

Rassulova M.A.

GBUZ "MNPTs meditsinskoĭ reabilitatsii, vosstanovitel'noĭ i sportivnoĭ meditsiny" Departamenta zdravookhraneniia Moskvy

Sichinava N.V.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr meditsinskoĭ reabilitatsii i kurortologii" Minzdravsotsrazvitiia Rossii, Moskva

Morozova N.E.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr meditsinskoĭ reabilitatsii i kurortologii" Minzdrava Rossii

Close metadata

References:

Gavrilova N.A. Patogeneticheskie mekhanizmy razvitiya diabeticheskoy retinopatii, diagnostika rannikh stadiy. Prognoz i profilaktika razvitiya, differentsirovannyy podkhod k lecheniyu: Avtoref. dis. … d-ra med. nauk. M.; 2004; 47 [The pathogenetic mechanisms of the development of diabetic retinopathy. Diagnostics of the early stages. Prognostication and prophylaxis of the development. Differential approach to the treatment: Summary of the thesis for the degree of doctor of medical sciences. M.; 2004; 47].[In Russian].
Bobrovnitskiy I.P., Lebedeva O.D., Yakovlev M.Yu. Otsenka funktsional'nykh rezervov organizma i vyyavlenie lits grupp riska rasprostranennykh zabolevaniy grupp riska rasprostranennykh zabolevaniy [The estimation of the functional reserves of the body and the identification of the subjects at risk of developing common diseases]. Voprosy kurortologii, fizioterapii i lechebnoy fizicheskoy kul'tury. 2011; 6: 40-43.[In Russian].
Zakharov V.D. Vitreoretinal'naya mikrokhirurgiya. M.; 2003 [Vitreoretinal microsurgery. M.; 2003].[In Russian].
Lazarenko N.N., Gerasimenko M.Yu. Elektrostimulyatsiya bipolyarno-impul'snymi tokami i galantamin-elektroforez v reabilitatsii bol'nykh sakharnym diabetom [The use of electrical stimulation with bipolar-pulsed currents and galantamine electrophoresis for the rehabilitation of the patients with diabetes mellitus]. Voprosy kurortologii, fizioterapii i lechebnoy fizicheskoy kul'tury. 2011; 6: 16-20.[In Russian].
Castillo M., Bellot J.L., Garcia-Cabanes C., Miquel J., Orts A., Palmero M. Eff ects of hypoxia on retinal pigmented epithelium cells: protection by antioxidants. Ophthalmic Res. 2002; 34 (6): 338-42.
Mattews D.R., Stratton I.M., Aldington S.J., Holman R.R., Kohner E.M.; UK Prospective Diabetes Study Group. Risks of progression of retinopathy and vision loss related. Arch. Ophthalmol. 2004; 122 (11): 1631-40.
Smith S.C. Focus on diabetes. Insight. 2006; 31 (1): 21-2.
Isakova Z.Zh. Kompleksnoe lechenie neproliferativnoy diabeticheskoy retinopatii: Avtoref. dis. … kand. med. nauk. M.; 2002; 24 [The combined treatment of non-proliferative diabetic retinopathy: Summary of the thesis for the degree of candidate of medical sciences. M.; 2002; 24].[In Russian].
Ashmarin I.P., Nezavibat'ko V.N., Myasoedov N.F., Grivennikov I.A., Ponomareva-Stepnaya M.A., Andreeva L.A., Kaplan A.Ya., Koshelev V.B., Ryasina T.V. Nootropnyy analog adrenokortikotropina 4-10 - Semaks (15-letniy opyt razrabotki i izucheniya) [The nootropic analog of adrenocorticotropin4-10 - Semaks (15 year experience with the development andinvestigations] . Zhurnal vysshey nervnoy deyatel'nosti im. I.P. Pavlova. 1997; 47 (3): 420-430.[In Russian].
Marchenko L.N. Neyroprotektsiya pri zabolevaniyakh setchatki i zritel'nogo nerva. Minsk: UP IVTs Minfina; 2003; 363 [Neuroprotection in the patients presenting with retinal and optic nerve pathology. Minsk: UP IVTs Minfina; 2003; 363].[In Russian].
Polunin G.S., Nurieva S.M., Bayandin D.L., Sheremet N.L., Andreeva L.A. Opredelenie terapevticheskoy effektivnosti novogo otechestvennogo preparata Semaks pri zabolevaniyakh zritel'nogo nerva [The assessment of the therapeutic effectiveness of the new domestic preparation Semak for the treatment of optic nerve pathology]. Vestnik oftal'mologii. 2000; 116 (1): 15-18.[In Russian].